| Literature DB >> 33917363 |
Anelise Sonza1, Danúbia da Cunha de Sá-Caputo2,3, Alessandro Sartorio4, Sofia Tamini4, Adérito Seixas5, Borja Sanudo6, Jessica Süßenbach7, Marcello Montillo Provenza8, Vinicius Layter Xavier8, Redha Taiar9, Mario Bernardo-Filho2.
Abstract
OBJECTIVE: To evaluate the impact of the COVID-19 pandemic and the following lockdown on physical exercise (PEx) practice, pain, and psychological well-being. <br> METHODS: A cross-sectional multicentric study was performed using a nonrandom convenience sampling from the general population (≥18 years-old) of 6 countries (Brazil, Italy, France, Portugal, Germany, and Spain) adopting social isolation (SI). The validated self-administered online survey (PEF-COVID19) was used. The tests T-test and Chi-square with Bonferroni correction were used for statistical analysis and a multivariate logistic regression model (p ˂ 0.05). <br> RESULTS: We included 3194 replies and ~80% of the respondents were in SI. Brazilian sample was highly influenced by the pandemic considering PEx practice and habits, pain, anxiety, and stress (p ˂ 0.05). Among the European countries, Italy presented the major changes. The model to predict the non-practice of PEx during SI showed that the variables countries, smoking, SI, and PEx level were significant predictors (p ˂ 0.001). <br> CONCLUSION: The pandemic changed the PEx practice and habits, and the psychological well-being of populations in different manners. Countries, smoking, SI, and PEx level were predictors for the non-practice of PEx. Public health strategies are suggested to avoid sedentary lifestyles and quality of life decrease.Entities:
Keywords: SARS-CoV-2; anxiety; pain; physical exercise; social isolation; stress; survey
Year: 2021 PMID: 33917363 PMCID: PMC8038730 DOI: 10.3390/ijerph18073810
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Number of respondents per millions of people of the countries’ inhabitants.
| Country | Inhabitants | Number of Respondents | Respondents Per Million of Person (%) |
|---|---|---|---|
| Brazil * | 211,552,573 | 1845 | 8.8 |
| Italy ᵜ | 60,470,911 | 680 | 11.2 |
| France ᵜ | 65,258,681 | 236 | 3.4 |
| Portugal ᵟ | 10,276,617 | 152 | 14.7 |
| Germany ᵜ | 83,756,401 | 143 | 1.7 |
| Spain ᵝ | 47,100,396 | 138 | 3.1 |
| Overall | 478,415,579 | 3194 | 6.7 |
Legend: * IBGE, Instituto Brasileiro de Geografia e Estatística (https://www.ibge.gov.br/apps/populacao/projecao/box_popclock.php); ᵜ https://www.worldometers.info/population/europe/; ᵟ Instituto Nacional de Estatística Português (https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_indicadores&indOcorrCod=0001223&contexto=bd&selTab=tab2&xlang=pt); ᵝ Instituto Nacional de Estadística (INE). (https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176951&menu=ultiDatos&idp=1254735572981). All websites were accessed on 23 May 2020.
Sociodemographic characteristics of the sample from Brazil (n = 1845), Italy (n = 680), France (n = 236), Germany (n = 143), Portugal (n = 152) and Spain (n = 138), aged from 18 years old (n = 3195). Values are presented as mean ± SD or percentage (%).
| Brazil | Italy | France | Germany | Portugal | Spain | Overall | |
|---|---|---|---|---|---|---|---|
|
| 39.5 ± 13.3 * | 42.9 ± 14.6 * | 32.9 ± 10.7 | 30.4 ± 10.7 * | 26.5 ± 7.8 * | 33.8 ± 10.8 | 38.4 ± 13.6 |
| Young (18–24 years) | 21.8 ± 1.6 (14.7) | 22.6 ± 1.5 (12.3) | 21.2 ± 1.8 (29.7) | 21.5 ± 1.6 (34) | 21.5 ± 1.3 (59.4) ᵜ | 22.1 ± 1.5 (17) | 21.8 ± 1.6 (18.6) |
| Young-Adult (25–44 years) | 34.7 ± 5.7 (53.3) | 33.1 ± 5.8 (38.7) | 34 ± 6.4 (52.1) | 31.5 ± 4.9 (54.7) | 32.8 ± 6.7 (39.3) | 32.9 ± 4.7 (72.5) | 34 ± 5.8 (50.4) |
| Adult (45–59 years) | 51.8 ± 4.2 (23.4) | 52.5 ± 4.1 (35.3) ᵜ | 49.5 ± 3.5 (17.4) | 51.4 ± 3.5 (9.9) | 49.5 ± 3.5 (1.3) | 54.6 ± 4.5 (4.2) | 51.9 ± 4.2 (22.8) |
| Elderly (60- years) | 65.5 ± 4.6 (8.6) | 65 ± 4.6 (13.7) | 0 (0) | 72.5 ± 4.9 (1.4) | 0 (0) | 63.3 ± 2.4 (6.3) | 65.3 ± 4.6 (8.2) |
|
| |||||||
| Female | 70 | 68.7 | 55.5 | 69.9 | 57.2 | 38.4 ᵜ | 66.7 |
| Male | 29.8 | 30.1 | 44.5 | 30.1 | 42.8 | 61.6 ᵜ | 32.9 |
| Not declared | 0.2 | 1.2 | 0 | 0 | 0 | 0 | 0.4 |
|
| |||||||
| Mass (kg) | 70.9 ± 14.9 | 70 ± 18.5 | 69.6 ± 12.7 | 70.2 ± 11.9 | 68.4 ± 12.6 ᵟ | 72.3 ± 11.9 | 70.5 ± 15.3 |
| Height (m) | 1.67 ± 0.1 * | 1.68 ± 0.1 * | 1.72 ± 0.1 | 1.75 ± 0.1 ᵝ | 1.7 ± 0.1 * | 1.73 ± 0.1 | 1.68 ± 0.9 |
| BMI (kg/m2) | 25.3 ± 4.3 * | 24.6 ± 5.9 ® | 23.4 ± 3.2 | 22.9 ± 2.8 ᵟ | 23.8 ± 4.4 | 23.9 ± 2.9 | 24.8 ± 4.6 |
|
| |||||||
| Not married | 38.3 ᵜ | 40.1 | 55.8 | 64.6 | 78.9 ᵜ | 50 | 43.6 |
| Married / in a stable relationship | 50.8 | 51.5 | 36.6 | 34.7 | 17.1 ᵜ | 49.3 | 47.6 |
| Divorced | 9.4 | 6.2 | 7.2 | 0.7 | 3.3 | 0.7 | 7.5 |
| Widowed | 1.5 | 2.2 | 0.4 | 0 | 0.7 | 0 | 1.4 |
|
| |||||||
| Elementary school | 0.4 | 0.3 | 0 | 0 | 0 | 0 | 0.3 |
| Secondary school | 0 | 9.4 ᵜ | 10.2 | 2.8 | 0 | 12.3 | 3.4 |
| High school | 7.9 ᵜ | 33.1 ᵜ | 79.6 ᵜ | 40.5 | 18.4 | 0 | 20.2 |
| Undergraduate | 35 | 40 | 5.9 ᵜ | 18.2 | 65.8 ᵜ | 59.4 | 35.5 |
| Graduation (masters, doctorate) | 56.7 ᵜ | 17.2 ᵜ | 4.3 ᵜ | 38.5 | 15.8 | 28.3 | 40.5 |
|
| |||||||
| University profession | 63.9 | 58 | 61.3 | 46.7 | 34.7 ᵜ | 78.1 | 60.9 |
| Nonuniversity profession | 7.8 ᵜ | 30.4 ᵜ | 38.3 ᵜ | 5.2 | 5.3 | 4.4 | 14.5 |
| Retired | 7.3 | 4.4 | 0 | 0.7 | 0 | 0.7 | 5.2 |
| Student | 16.8 | 7.2 ᵜ | 0.4 ᵜ | 47.4 ᵜ | 60 ᵜ | 16.8 | 16.9 |
| Military | 4.2 ᵜ | 0 | 0 | 0 | 0 | 0 | 2.4 |
|
| |||||||
| Student | 15.5 ᵜ | 7.5 ᵜ | 46.4 ᵜ | 50.3 ᵜ | 67.1 ᵜ | 16.7 | 20.1 |
| Public sector | 30 | 20.7 | 13.6 | 34.3 | 10.5 | 24.6 | 25.9 |
| Private sector | 28.3 | 40 ᵜ | 24.7 | 7 | 12.5 | 30.4 | 28.9 |
| Unemployed | 6.5 | 7.9 | 3.8 | 2.1 | 4.6 | 6.5 | 6.3 |
| Retired | 7 | 7.9 | 0.4 | 1.4 | 0 | 2.2 | 5.9 |
| SR/U | 12.7 | 16 | 11.1 | 4.9 | 5.3 | 19.6 | 12.9 |
Legend: BMI, body mass index; SR/U, Salary reduction or unemployed due to COVID-19; T-test for independent samples, * when all countries are different between themselves; ® difference of France and Germany; ᵝ difference of France; ᵟ difference of Spain p < 0.05. ᵜ Chi-square test for categorical variables, comparisons between countries, with Bonferroni correction p < 0.05.
Current health conditions of the sample from Brazil (n = 1845), Italy (n = 680), France (n = 236), Germany (n = 143), Portugal (n = 152) and Spain (n = 138), aged from 18 years old (n = 2860). Values are presented as percentage (%).
| Brazil | Italy | France | Germany | Portugal | Spain | Overall | |
|---|---|---|---|---|---|---|---|
|
| |||||||
| CD&RC | 10.2 | 17.8 | 4.3 | 2.8 | 3.9 | 2.2 | 10.4 |
| ND | 0.6 | 0.6 | 1.3 | 1.4 | 0 | 0.7 | 0.7 |
| RD | 14 | 5.1 | 4.7 | 9.1 | 9.9 | 5.1 | 10.6 |
| MD | 10.7 | 7.5 | 6.0 | 4.9 | 5.9 | 8.7 | 9.1 |
| MH | 8.4 | 3.5 | 5.1 | 4.9 | 7.2 | 2.2 | 6.6 |
| No disease | 56 | 65.4 | 78.7 | 76.9 | 73 | 81.2 | 62.5 |
|
| |||||||
| Yes/No (%) | 38/62 | 38.2/61.8 | 18.7/81.3 | 23.1/76.9 | 18.4/81.6 | 18.8/81.2 | 34.2/65.8 |
|
| |||||||
| CD&RC/C2+ | 6.9/6.3 | 6.2/1.5 | 2.1/0 | 1.4/0 | 0/0 | 2.2/0 | 5.6/4 |
| ND/C2+ | 0.3/0.5 | 0.3/0.1 | 0/0 | 0.7/0 | 0/0 | 0/0 | 0.3/0.3 |
| RD&A/C2+ | 2.1/2.1 | 1.9/0.6 | 5.1/0 | 7/0 | 3.3/2 | 7.2/0 | 2.8/1.4 |
| MD/C2+ | 0.8/1.6 | 1.9/0.3 | 1.7/0 | 1.4/0 | 0/0.7 | 1.4/0 | 1.1/1 |
| MH/C2+ | 5.1/3.1 | 1.8/0.6 | 2.5/0 | 1.4/0 | 1.3/2 | 0/0 | 3.6/2 |
| TH/C2+ | 3.5/2.8 | 2.8/1.2 | 1.7/0 | 6.3/0 | 2.7/0 | 5.1/0 | 3.4/1.9 |
| CP/C2+ | 3.7/1.3 | 4/1.3 | 1.7/0 | 2.1/0 | 4.7/2 | 2.2/0 | 3.5/1.1 |
| Food supplements/C2+ | 1.7/2.5 | 0.7/0 | 0/0 | 0/0 | 0/0.7 | 0/0 | 1.1/1.5 |
| Other/C2+ | 1.8/3.5 | 0.6/0.6 | 3.8/0 | 0.7/0 | 2.7/1.3 | 2.2/0 | 1.7/2.2 |
|
| |||||||
| Yes(%)/years smoking | 4.1 ᵜ/18.6 ± 11.6 | 17.6 ᵜ/17.3 ± 12 | 15.7/15 ± 9 | 2.8/13.5 ± 11.6 | 16.4/8.9 ± 6 ᵝ | 12.3/19 ± 10.8 | 8.7/16.5 ± 10.9 |
| 10 ± 9.9 | 9.7 ± 8.7 | 9.9 ± 6.7 | 4.1 ± 4.1 | 8.4 ± 5.2 | 8.6 ± 6 | 9.5 ± 6.7 | |
| No | 95.9 | 82.4 | 84.3 | 97.2 | 83.6 | 87.7 | 91.3 |
Legend: CD&RC, cardiovascular diseases and related conditions, * antidiabetic, hypocholesterolemic, antihypertensive, anticoagulants and beta-blockers; C2+, combined with two or more medicaments from any category; ND, neurological diseases, * antiepileptic; RD&A, respiratory diseases and allergy, * antihistaminic and antiasthmatic; MD, musculoskeletal, * corticosteroids, antiosteoporosis, nonsteroidal antiinflammatory, painkillers; MH, mental health, * psychotropic; TH, thyroid hormones; CP, contraception, * contraceptive pill; Other, * antiacid, antitumoral, others. ᵜ Chi-square test (p < 0.05) for categorical variables, comparisons between countries, with Bonferroni correction. T test for independent samples, ᵝ Portugal was different from Brazil, Italy, France and Spain.
Figure 1Number of individuals (%) in social isolation (A) and reasons why the individual was not isolated (B). Sample constituted by general population aged from 18 years old from Brazil (n = 1845), Italy (n = 680), France (n = 236), Germany (n = 143), Portugal (n = 152), and Spain (n = 138). Legend: BR, Brazil; IT, Italy; FR, France; GE, Germany; PO, Portugal; SP, Spain.
Physical exercise practice and habits, and self-related fatigue of the sample from Brazil (n = 1845), Italy (n = 680), France (n = 236), Germany (n = 143), Portugal (n = 152) and Spain (n = 138), aged from 18 years old (n = 3194), before and during the COVID-19 pandemic. Values are presented as percentages (%).
| PEx Practice before COVID-19 | PEx Practice during COVID-19 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brazil | Italy | France | Germany | Portugal | Spain | Overall | Brazil | Italy | France | Germany | Portugal | Spain | Overall | ||
| SR Level of PEx | |||||||||||||||
| Sedentary | 14.8 | 11.9 | 3.8 | 2.8 | 12.5 | 2.9 | 12.2 | 28.9 ᵜ | 25.6 ᵜ | 11.5 | 8.4 | 22.4 | 13 | 25 ᵜ | |
| A bit active | 24.4 | 35.6 | 32.8 | 14.7 | 34.2 | 18.1 | 27.1 | 33.2 ᵜ | 39.8 | 28.1 | 32.9 | 28.3 | 32.6 | 34 ᵜ | |
| Active | 43.7 | 43.7 | 47.7 | 52.4 | 31.6 | 52.2 | 44.2 | 32 ᵜ | 27.5 ᵜ | 37.4 | 48.2 | 36.8 | 39.2 | 32.7 ᵜ | |
| Very active | 17.1 | 8.8 | 15.7 | 30.1 | 21.7 | 26.8 | 16.5 | 5.9 ᵜ | 7.1 | 23 | 10.5 | 12.5 | 15.2 | 8.3 ᵜ | |
| PEx Practice | |||||||||||||||
| Yes | 80.4 | 72.8 | 92.8 | 95.8 | 70.4 | 92.8 | 80.5 | 71 | 68.5 | 82.6 | 93 | 76.3 | 88.4 | 73.4 ᵜ | |
| No | 19.6 | 27.2 | 7.2 | 4.2 | 29.6 | 7.2 | 19.5 | 29 ᵜ | 31.5 | 17.4 ᵜ | 7 | 23.7 | 11.6 | 26.6 ᵜ | |
| Frequency | |||||||||||||||
| 1 t/w | 4.7 | 13 | 18.7 | 3.6 | 8.9 | 3.1 | 7.6 | 9.1 ᵜ | 10.7 | 6.9 | 5.2 | 9.6 | 4.1 | 8.9 ᵜ | |
| 2–3 | 45.6 | 57.5 | 52.3 | 30.5 | 46.4 | 34.9 | 47.5 | 40.6 ᵜ | 35.4 ᵜ | 30.7 ᵜ | 35.8 | 27.8 | 23.6 | 37.2 ᵜ | |
| 4–5 | 33.2 | 23 | 20.9 | 44.9 | 35.8 | 43.4 | 31.2 | 32.2 ᵜ | 30.3 | 30.3 | 36.6 | 37.4 | 35.8 | 32.3 ᵜ | |
| 6–7 | 16.5 | 6.5 | 8.1 | 21 | 8.9 | 18.6 | 13.7 | 18.1 ᵜ | 23.6 ᵜ | 32.1 ᵜ | 22.4 | 25.2 | 36.5 | 21.6 ᵜ | |
| Duration | |||||||||||||||
| 0–30 min | 5.6 | 8.4 | 11.1 | 3.7 | 5.6 | 3.1 | 6.4 | 30.4 ᵜ | 38.1 ᵜ | 15.6 | 15.1 | 22.6 | 11.6 | 29.1 ᵜ | |
| 31–60 | 14.4 | 14.4 | 20.8 | 17.6 | 17 | 12.5 | 15.1 | 28 ᵜ | 26.2 ᵜ | 25.7 | 31.1 | 30.4 | 28.1 | 27.7 ᵜ | |
| 61- | 80 | 77.2 | 68.1 | 78.7 | 77.4 | 84.4 | 78.5 | 41.6 ᵜ | 35.7 ᵜ | 58.7 | 53.8 | 47 ᵜ | 60.3 | 43.2 ᵜ | |
| PEx type | |||||||||||||||
| Aerobic | 44.4 | 77.8 | 73.1 | 51.1 | 37.6 | 39.4 | 53.4 | 54.9 ᵜ | 74.2 | 56.9 | 70.1 | 59.3 | 27.9 | 58.9 ᵜ | |
| Resistance ‡ | 10.3 | 4.7 | 20.1 | 2.9 | 15.6 | 13.4 | 9.9 | 21.2 ᵜ | 12.7 | 31.2 | 3.8 | 30.1 | 29.5 | 20.1 ᵜ | |
| Strengthening ‡‡ | 28.9 | 4.7 | 6.8 | 12.4 | 31.2 | 25.2 | 21.3 | 11.6 ᵜ | 5.5 | 11.9 | 9.7 | 7.1 | 16.4 | 10.2 ᵜ | |
| Other/CM | 16.4 | 12.8 | 0 | 33.6 | 15.6 | 22 | 15.4 | 12.3 | 7.6 | 0 | 16.4 | 3.5 | 26.2 | 10.8 ᵜ | |
| SR Fatigue PEx | |||||||||||||||
| 0–3 | 28.6 | 21.9 | 21.8 | 17.9 | 12.5 | 3.9 | 24.4 | 24.2 | 24.2 | 25.7 | 23.7 | 15.7 | 9 | 23.2 ᵜ | |
| 4–7 | 50.8 | 64.1 | 70.9 | 62.1 | 71.4 | 65.4 | 57.2 | 52.9 | 59.9 | 68.3 | 57.8 | 67 | 63.9 | 56.9 ᵜ | |
| 8–10 | 20.6 | 14 | 7.3 | 20 | 16.1 | 30.7 | 18.4 | 22.9 | 15.9 | 6 | 18.5 | 17.3 | 27.1 | 19.9 ᵜ | |
| Motivation | |||||||||||||||
| Entertainment | 7.8 | 22.8 | 7.7 | 18.1 | 21.4 | 11 | 12.2 | 8.2 | 28.7 | 15.1 | 6.7 | 23.5 | 11.4 | 13.8 ᵜ | |
| Performance | 10 | 11 | 31.9 | 24.6 | 15.2 | 17.3 | 13.1 | 5.6 ᵜ | 8.2 | 3.7 ᵜ | 14.2 | 7.8 | 12.2 | 6.8 ᵜ | |
| Aesthetics | 9.8 | 20.5 | 32.8 | 10.9 | 17 | 3.9 | 13.9 | 7.1 | 20.1 | 40.4 | 9 | 14.8 | 7.3 | 12.8 ᵜ | |
| Health | 72.4 | 45.7 | 27.6 | 46.4 | 46.4 | 67.8 | 60.8 | 79.1 ᵜ | 43 | 40.8 | 70.1 | 53.9 | 69.1 | 66.6 ᵜ | |
| Period PEx | |||||||||||||||
| Dawn | 1.5 | 10.5 | 3.8 | 5.8 | 0.9 | 6.2 | 4 | 0.7 | 14.1 | 2.3 | 9 | 0.9 | 4.1 | 4.2 ᵜ | |
| Morning | 45.7 | 30.4 | 20.4 | 16.7 | 22.5 | 27.2 | 37.4 | 42.5 | 73.7 ᵜ | 30.7 | 25.6 | 16.5 | 25.2 | 45.6 ᵜ | |
| Afternoon | 19.1 | 53.8 | 57.4 | 68.8 | 57.7 | 55 | 35 | 31.5 ᵜ | 9.4 ᵜ | 61 | 60.2 | 80 | 67.5 | 34.1 ᵜ | |
| Night | 33.7 | 5.3 | 18.2 | 8.7 | 18.9 | 11.6 | 23.7 | 25.3 ᵜ | 2.8 | 6 | 5.2 | 2.6 | 3.2 | 16.2 ᵜ | |
Legend: PEx, Physical Exercise; TS, total sample; SR, self-related; t/w, times/week; min, minutes; CM, combined modalities; ‡ for strength exercise types: free weights and elastic bands; ‡‡ for strength exercise types: weight training with machines or lifting weights; ᵜ Chi-square test (p < 0.05) with Bonferroni correction for categorical variables, comparisons intracountries, before and during COVID-19.
Results of the multivariate logistic regression for the nonpractice of PEx during the quarantine period for the overall sample (n = 3195).
| Data File | β |
|
|
|
| 95% CI | |
|---|---|---|---|---|---|---|---|
| Brazil | 0.335 | 0.248 | 1.352 | 1709 | 0.176 | 1.398 | [0.859, 2.270] |
| Italy | 0.180 | 0.255 | 0.707 | 644 | 0.480 | 1.197 | [0.726, 1.970] |
| Portugal | −0.029 | 0.303 | −0.097 | 150 | 0.923 | 0.971 | [0.533, 1.751] |
| Germany | −1.010 | 0.419 | −2.413 | 141 | 0.016 * | 0.364 | [0.153, 0.801] |
| Spain | −0.417 | 0.369 | −1.131 | 137 | 0.258 | 0.659 | [0.313, 1.336] |
| France | −0.008 | 0.286 | −0.028 | 232 | 0.978 | 0.992 | [0.563, 1.730] |
| Gender (male) | 0.088 | 0.101 | 0.867 | 1002 | 0.386 | 1.091 | [0.895, 1.330] |
| Gender (prefer not to say) | 0.804 | 0.722 | 1.112 | 10 | 0.266 | 2.234 | [0.509, 9.007] |
| Smoking (no) | −0.314 | 0.159 | −1.971 | 2748 | 0.049 * | 0.73 | [0.536, 1.001] |
| Age (2544) | 0.211 | 0.141 | 1.493 | 1519 | 0.135 | 1.235 | [0.939, 1.634] |
| Age (45–59) | 0.247 | 0.160 | 1.548 | 689 | 0.122 | 1.28 | [0.938, 1.754] |
| Age (more than 60) | 0.368 | 0.200 | 1.841 | 247 | 0.066 | 1.445 | [0.976, 2.139] |
| PEx practice (no) | 0.706 | 0.126 | 5.584 | 585 | <0.001 * | 2.026 | [1.581, 2.596] |
| PEx level (insuf. active) | −1.017 | 0.146 | −6.972 | 807 | <0.001 * | 0.362 | [0.271, 0.481] |
| PEx level (active) | −2.035 | 0.162 | −12.571 | 1334 | <0.001 * | 0.131 | [0.095, 0.179] |
| PEx level (very active) | −2.720 | 0.223 | −12.206 | 503 | <0.001 * | 0.066 | [0.042, 0.101] |
| Social isolation (no) | 0.590 | 0.132 | 4.471 | 455 | <0.001 * | 1.805 | [1.392, 2.336] |
| Social isolation (have been) | 0.449 | 0.180 | 2.499 | 208 | 0.012 * | 1.566 | [1.097, 2.219] |
Legend: β = regression coefficient; df = degrees of freedom; OR = odds ratio; CI = confidence interval. * p < 0.05.
Level of pain and psychological impact of the sample from Brazil (n = 1845), Italy (n = 680), France (n = 236), Germany (n = 143), Portugal (n = 152) and Spain (n = 138), aged from 18 years old (n = 3194), before and during the COVID-19 pandemic. Values are presented as percentages (%).
| Pain, Anxiety, and Stress Before COVID-19 | Pain, Anxiety, and Stress during COVID-19 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brazil | Italy | France | Germany | Portugal | Spain | Overall | Brazil | Italy | France | Germany | Portugal | Spain | Overall | |
| Pain | ||||||||||||||
| Yes | 34.6 | 33.5 | 41.7 | 24.5 | 27.6 | 31.9 | 34 | 44 ᵜ | 44.4 ᵜ | 35 | 29.4 | 38.2 | 40.6 | 42.3 ᵜ |
| No | 65.4 | 66.5 | 58.3 | 75.5 | 72.4 | 68.1 | 66 | 56 | 55.6 | 65 | 70.6 | 61.8 | 59.4 | 57.7 ᵜ |
| Pain BR ‡ | ||||||||||||||
| H& | 4.1 | 10.2 | 7 | 8.5 | 3.9 | 4.5 | 5.8 | 8.2 ᵜ | 13.8 | 7.5 | 6.8 | 5.4 | 5.7 | 9 ᵜ |
| UL | 4.6 | 6.8 | 7.7 | 6.6 | 5.1 | 5.2 | 5.4 | 6.3 | 10.1 | 3.8 | 4.1 | 8 | 9.3 | 7 ᵜ |
| Back | 15.8 | 11.7 | 10.6 | 0.9 | 11.6 | 9.8 | 13.4 | 18.4 | 13.6 | 15.4 | 8.2 | 16.1 | 16.4 | 16.5 ᵜ |
| Hip | 2.6 | 1.6 | 7.7 | 1.9 | 0.6 | 2.6 | 2.6 | 2.7 | 1.6 | 0 | 2.1 | 0.7 | 0.7 | 2.1 ᵜ |
| LL | 7.4 | 3.2 | 8.8 | 6.6 | 6.4 | 9.8 | 6.6 | 8.4 | 5.3 | 8.3 | 8.2 | 8 | 8.5 | 7.7 ᵜ |
| Level of pain ≈ | ||||||||||||||
| 0–3 | 33.6 | 22.8 | 14.6 | 33.3 | 39.5 | 21.2 | 29.6 | 28.7 | 22.2 | 31 | 36.4 | 29.8 | 21.2 | 27.6 ᵜ |
| 4–7 | 55.6 | 66.8 | 72.5 | 55.6 | 51.2 | 59.6 | 59.2 | 55.1 | 60.6 | 52.4 | 50 | 61.4 | 63.6 | 56.5 ᵜ |
| 8–10 | 10.8 | 10.4 | 12.9 | 11.1 | 9.3 | 19.2 | 11.2 | 16.2 ᵜ | 17.2 | 16.6 | 13.6 | 8.8 | 15.2 | 15.9 ᵜ |
| Level of Anxiety ≈ | ||||||||||||||
| 0–3 | 42.8 | 60.6 | 56.6 | 78.4 | 59.8 | 55.1 | 50.6 | 21.6 ᵜ | 40.9 ᵜ | 41.3 | 63.7 | 38.2 | 32.6 | 30.4 ᵜ |
| 4–7 | 47.3 | 33.6 | 35.8 | 19.5 | 37.5 | 36.3 | 41.3 | 44.3 | 43 | 44.6 | 32.2 | 44.7 | 52.9 | 43.9 ᵜ |
| 8–10 | 9.9 | 5.8 | 7.6 | 2.1 | 2.7 | 8.6 | 8.1 | 34.1 ᵜ | 16.1 ᵜ | 14.1 | 4.1 | 17.1 | 14.5 | 25.8 ᵜ |
| Level of Stress ≈ | ||||||||||||||
| 0–3 | 34.1 | 34.3 | 48.1 | 36.4 | 46.7 | 27.5 | 35.6 | 26.7 ᵜ | 34.8 | 42.6 | 41.3 | 36.8 | 39.9 | 31.3 ᵜ |
| 4–7 | 52 | 49.9 | 42.1 | 45.5 | 46.7 | 50.7 | 50.2 | 43.4 ᵜ | 44.7 | 44.3 | 39.9 | 46.1 | 44.1 | 43.7 ᵜ |
| 8–10 | 13.9 | 15.8 | 9.8 | 18.1 | 6.6 | 21.8 | 14.2 | 29.9 ᵜ | 20.5 | 13.1 | 18.8 | 17.1 | 16 | 25 ᵜ |
Legend: PE, physical Exercise; BR, body regions; ‡ values are relative to the respondents with pain; H&n, head and neck; UL, upper limbs; LL, lower limbs. ≈ values are relative to the given answers (100%); ᵜ Chi-square test (p < 0.05) with Bonferroni correction for categorical variables, comparisons intracountries, before and after COVID-19.